

So far, various approaches have been proposed to improve dermal drug delivery. The use of chemical penetration enhancers has a long history of application, while methods based on the electrical current (such as iontophoresis) stand out as promising “active” techniques. Aiming to evaluate the contribution of different approaches to dermal delivery, in this work curcumin-loaded nanoemulsions with and without monoterpenes (eucalyptol or pinene) as chemical penetration enhancers, and a custom-made adhesive dermal delivery system based on iontophoresis were designed and assessed. In an in vivo study applying skin bioengineering techniques, their safety profile was proven. Three examined iontophoresis protocols, with total skin exposure time of 15 min (continuous flow for 15 min (15-0); 3 min of continuous flow and 2 min pause (3-2; 5 cycles) and 5 min of continuous flow and 1 min pause (5-1; 3 cycles) were equally efficient in terms of the total amount of curcumin that penetrated through the superficial skin layers (in vivo tape stripping) (Q3-2 = 7.04 ± 3.21 μg/cm2; Q5-1 = 6.66 ± 2.11 μg/cm2; Q15-0 = 6.96 ± 3.21 μg/cm2), significantly more efficient compared to the referent nanoemulsion and monoterpene-containing nanoemulsions. Further improvement of an efficient mobile adhesive system for iontophoresis would be a practical contribution in the field of dermal drug application. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
| EMTREE drug terms: | cineolecurcuminpinene |
|---|---|
| EMTREE medical terms: | adultArticlebioengineeringcytotoxicity testdrug formulationdrug penetrationdrug safetyflow ratehumanhuman cellhuman experimentin vivo studyiontophoresisnanoemulsionpHskin penetrationtissue engineeringzeta potential |
cineole, 470-82-6, 55962-72-6; curcumin, 458-37-7; pinene, 80-56-8
Drug manufacturer:
Sigma Aldrich, United States
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| 451-03-68/2022-14/200161 | ||
| UK Research and Innovation | 105135 | UKRI |
| 200161 |
Funding: This research was funded by the Ministry of Education, Science and Technological Development of the Republic of Serbia through the Grant Agreement with University of Belgrade\u2014Faculty of Pharmacy No. 451-03-68/2022-14/200161.
Marković, B.; Department of Pharmaceutical Chemistry, University of Belgrade, Faculty of Pharmacy, Belgrade, Serbia;
© Copyright 2022 Elsevier B.V., All rights reserved.